Ipca Labs
₹1,832.6-80.50 (-4.21%)as of 2026-10-16
- Market Cap
- ₹46,830Cr.
- P/E Ratio
- 34.1
- P/B Ratio
- 5.76
- EPS (TTM)
- ₹53.74
- Day Range
- ₹1,813.2 – ₹1,907.1
- Div Yield
- 0.31%
- ROCE
- 17%
- ROE
- 15.7%
52W Low: ₹1,25252W High: ₹2,038
Themes:💊 Pharma & CDMO
Appears in 1 screen
Descriptive screens built from published data — not investment advice.
At a glance
- Sales have grown 16.0% a year over three years.
- Debt is 0.10× its shareholders’ equity.
From reported financials and exchange prices. Descriptive only, not advice.
Ipca_Labs — Price
Interval
Style
Failed: 503
Evenstocks Score
Middle third
Overall
Valuation
Quality
Fundamental
Growth
Investment Checklist
Quick assessment based on key parametersPerformance
N/ATrailing return unavailableValuation
P/E 34.1P/E: 34.1 | P/B: 5.76Growth
GrowingSales CAGR — 3Y: 16% · 1Y: 11%Profitability
ModerateROCE: 17% | ROE: 15.7%Key Metrics
Valuation
PEG Ratio 0.92
Price / Sales 4.62x
Price / FCF 96.4x
Book Value ₹318
Margins & returns
Operating Margin 22%
Net Margin 13.6%
Return on Assets 11.1%